← Back to search results

AwardedFind a Tender · award
BuyerThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
StatusAwarded
DeadlineNot published
ValueValue not published
Published24 May 2023

What is being bought

Supply of ERT medicines to NHS Scotland: NP92615 (a) Laronidase - Aldurazyme® NP92615 (b) Imiglucerase - Cerezyme® NP92615 (c) Agalsidase Beta - Fabrazyme® NP92615 (d) Alglucosidase Alfa - Myozyme®

Delivery location

UKM

Categories

Pharmaceutical products 33600000Pharmaceutical products 33600000

Lot details

Lot 1

The Framework Agreements are for the supply of ERT Medicines to NHS Scotland. The Framework Agreements have been awarded as single supplier framework agreements per line to one (1) Framework Participant.

What is included

ItemCategoryQuantity
1Pharmaceutical productsNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Pharmaceutical products (33600000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 334,8542 median · 122.5 average (2,278 of 4,854 with a bid count)5.8 average (2,723 of 4,854 with named award suppliers)Not published
Same buyer2481.5 median · 51.6 average (140 of 248 with a bid count)6.3 average (215 of 248 with named award suppliers)Not published
Delivery region: UKM5357 median · 50.7 average (303 of 535 with a bid count)7.7 average (431 of 535 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementYes
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleThis VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.
Rationale classificationsThe procurement falls outside the scope of application of the directive
Special regimeNot published
Covered byGPA
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Awards

Contracts

014763-2023-NP92619(a-d)-1

Statusactive
Value£4,011,280

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-03cef8
Latest release ID014763-2023
Latest release timestampWed May 24 2023 10:56:50 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statuscomplete
Procurement methodlimited
Procurement method detailsAward procedure without prior publication of a call for competition
Main procurement categorygoods
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release1
Contracts in latest release1
Parties in latest release3

Notice history

DateEventReference
24 May 2023award, contract014763-2023

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "014763-2023",
  "tag": [
    "award",
    "contract"
  ],
  "date": "2023-05-24T11:56:50+01:00",
  "ocid": "ocds-h6vhtk-03cef8",
  "buyer": {
    "id": "GB-FTS-322",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
  },
  "links": [
    {
      "rel": "prev",
      "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:339939-2019:TEXT:EN:HTML"
    },
    {
      "rel": "canonical",
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000730526"
    }
  ],
  "awards": [
    {
      "id": "014763-2023-NP92619(a-d)-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-11331",
          "name": "Aventis Pharma Ltd Trading As Sanofi"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "NP92619 (a-d)",
    "lots": [
      {
        "id": "1",
        "hasOptions": false,
        "description": "The Framework Agreements are for the supply of ERT Medicines to NHS Scotland.  The Framework Agreements have been awarded as single supplier framework agreements per line to one (1) Framework Participant."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "ERT Medicines",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "Supply of ERT medicines to NHS Scotland:\nNP92615 (a) Laronidase - Aldurazyme®\nNP92615 (b) Imiglucerase - Cerezyme®\nNP92615 (c) Agalsidase Beta - Fabrazyme®\nNP92615 (d) Alglucosidase Alfa - Myozyme®",
    "reviewDetails": "Economic operators should approach the contracting authority in the first instance.  However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established.  Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "goods",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-FTS-322",
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "countryName": "United Kingdom",
        "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
      },
      "details": {
        "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
      },
      "contactPoint": {
        "name": "Michelle Semple",
        "email": "michelle.semple3@nhs.scot"
      }
    },
    {
      "id": "GB-FTS-11331",
      "name": "Aventis Pharma Ltd Trading As Sanofi",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Reading",
        "postalCode": "RG6 1PT",
        "countryName": "United Kingdom",
        "streetAddress": "410 Thames Valley Park Drive"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Aventis Pharma Ltd Trading As Sanofi"
      }
    },
    {
      "id": "GB-FTS-324",
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "countryName": "United Kingdom",
        "streetAddress": "27 Chambers Street"
      },
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "014763-2023-NP92619(a-d)-1",
      "value": {
        "amount": 4011280,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "014763-2023-NP92619(a-d)-1",
      "dateSigned": "2023-05-24T00:00:00+01:00"
    }
  ],
  "description": "Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015.\nTotal value of the concession/lot (V2.4) covers the twelve (12) month extension period as covered in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.\nOJEU notice numbers for each of the individual Awards:\nNP92619(a)Aldurazyme®- 2019/S 170-415123\nNP92619(b)Cerezyme®- 2019/S 170-415129\nNP92619(c)Fabrazyme®- 2019/S 170-415117\nNP92619(d)Myozyme®- 2019/S 170-415133\n(SC Ref:730526)",
  "initiationType": "tender"
}
Complete JSON history (1 releases)
24 May 2023 · 014763-2023 · award, contract
{
  "id": "014763-2023",
  "tag": [
    "award",
    "contract"
  ],
  "date": "2023-05-24T11:56:50+01:00",
  "ocid": "ocds-h6vhtk-03cef8",
  "buyer": {
    "id": "GB-FTS-322",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
  },
  "links": [
    {
      "rel": "prev",
      "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:339939-2019:TEXT:EN:HTML"
    },
    {
      "rel": "canonical",
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000730526"
    }
  ],
  "awards": [
    {
      "id": "014763-2023-NP92619(a-d)-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-11331",
          "name": "Aventis Pharma Ltd Trading As Sanofi"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "NP92619 (a-d)",
    "lots": [
      {
        "id": "1",
        "hasOptions": false,
        "description": "The Framework Agreements are for the supply of ERT Medicines to NHS Scotland.  The Framework Agreements have been awarded as single supplier framework agreements per line to one (1) Framework Participant."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "ERT Medicines",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "Supply of ERT medicines to NHS Scotland:\nNP92615 (a) Laronidase - Aldurazyme®\nNP92615 (b) Imiglucerase - Cerezyme®\nNP92615 (c) Agalsidase Beta - Fabrazyme®\nNP92615 (d) Alglucosidase Alfa - Myozyme®",
    "reviewDetails": "Economic operators should approach the contracting authority in the first instance.  However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established.  Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "goods",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-FTS-322",
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "countryName": "United Kingdom",
        "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
      },
      "details": {
        "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
      },
      "contactPoint": {
        "name": "Michelle Semple",
        "email": "michelle.semple3@nhs.scot"
      }
    },
    {
      "id": "GB-FTS-11331",
      "name": "Aventis Pharma Ltd Trading As Sanofi",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Reading",
        "postalCode": "RG6 1PT",
        "countryName": "United Kingdom",
        "streetAddress": "410 Thames Valley Park Drive"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Aventis Pharma Ltd Trading As Sanofi"
      }
    },
    {
      "id": "GB-FTS-324",
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "countryName": "United Kingdom",
        "streetAddress": "27 Chambers Street"
      },
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "014763-2023-NP92619(a-d)-1",
      "value": {
        "amount": 4011280,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "014763-2023-NP92619(a-d)-1",
      "dateSigned": "2023-05-24T00:00:00+01:00"
    }
  ],
  "description": "Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015.\nTotal value of the concession/lot (V2.4) covers the twelve (12) month extension period as covered in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.\nOJEU notice numbers for each of the individual Awards:\nNP92619(a)Aldurazyme®- 2019/S 170-415123\nNP92619(b)Cerezyme®- 2019/S 170-415129\nNP92619(c)Fabrazyme®- 2019/S 170-415117\nNP92619(d)Myozyme®- 2019/S 170-415133\n(SC Ref:730526)",
  "initiationType": "tender"
}